Table 2.
Modifying factors | Clinical conditions | Major mechanisms | Relationship with ipsilateral DR |
---|---|---|---|
Vascular | Carotid obstructive disease | Carotid stenosis occurring after DR onset causes increased ischemia | Progression |
Carotid stenosis developing before DR with coexistent hypertension | Protection | ||
Ocular ischemic syndrome | Added ischemia | Progression | |
Retinal vascular diseases Unilateral BRVO Unilateral CRAO |
Thinning of inner retina Reduced retinal oxygen demand |
Protection | |
Inflammatory | Uveitis Acute retinal necrosis in Herpes Zoster infection Toxoplasmosis Other causes |
Blood-ocular barrier breakdown Vasculitis-induced ocular ischemia Free-radical induced damage Increased VEGF and intraocular cellular fibronectin Efflux of albumin and lymphocytes into aqueous and vitreous Juxtapapillary retinitis and vitritis in toxoplasmosis |
Progression |
Endophthalmitis | As in Uveitis Effect of cataract surgery and vitrectomy |
Progression | |
Fuch’s heterochromic iridocyclitis | Sympathetic denervation hypersensitivity, reflex vasoconstriction, reduced perfusion | Protection | |
Degenerative | Posterior vitreous detachment | Removal of scaffold for neovascularization Release of subtle tractions on retina |
Protection |
Axial refractive errors Unilateral, High or Anisomyopia Anisometropia>1D |
Reduced retinal metabolic demand Stretched vessel walls, increased pressure attenuation Effect of uveal coloboma and PVD Thinning of veins Dilution of VEGF |
Protection | |
Uveal coloboma | Lack of nutrition from the choroid in colobomatous area Outer retinal atrophy Relative decrease in oxygen demand |
Protection* | |
Retinitis pigmentosa | Greater oxygen and nutrient flux from choroid to inner retina Secondary attenuation of retinal blood vessels Early PVD Release of a cytokine that inhibits neovascularization from the retina Effect of Optic atrophy |
Protection | |
Healed choroiditis | Chorioretinal atrophy and scarring, reduced metabolic demand | Protection | |
Optic atrophy | Reduced metabolic demand | Protection | |
Surgery | Cataract surgery | Breakdown of blood-retinal barrier Increased inflammation including prostaglandin production |
Progression |
Vitrectomy | Increased diffusion and clearing of sequestered growth factors PVD Increased retinal oxygen saturation |
Protection | |
Miscellaneous | Elevated intraocular pressure and glaucoma | Decreased metabolic demand Decreased perfusion |
Protection |
Amblyopia, visual deprivation, and retinal detachment | Decreased metabolic demand Decreased perfusion |
Protection | |
Idiopathic |
DR=diabetic retinopathy, PVD=posterior vitreous detachment, VEGF=vascular endothelial growth factor. *Cannot be conclusively opined